Cardiovascular risk factors in chronic kidney disease

Slides:



Advertisements
Similar presentations
Chapter 1: Definition and classification of CKD Kidney International Supplements Volume 3, Issue 1, Pages (January 2013) DOI: /kisup
Advertisements

Navdeep Tangri, Paul V.J. Komenda, Claudio Rigatto 
Beta blockers in the management of chronic kidney disease
Volume 67, Pages S1-S7 (June 2005)
Uric Acid and Long-term Outcomes in CKD
Frederik Persson, Peter Rossing  Kidney International Supplements 
Brian Radbill, MD, Barbara Murphy, MD, Derek LeRoith, MD, PhD 
Mitchell H. Rosner, W. Kline Bolton  Kidney International 
Volume 83, Issue 3, Pages (March 2013)
Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure  Steven Fishbane, Nobuyuki Miyawaki  Kidney International 
Shining light on vitamin D trials in chronic kidney disease
Cardiovascular Disease and CKD: Core Curriculum 2010
Prehypertension and chronic kidney disease: the ox or the plow?
Status of chronic kidney disease prevention programs: International Federation of Kidney Foundation Members 2005/2007  Joanna M. Smith, Susan A. Mott,
Reassessment of the care of the patient with chronic kidney disease
John P. Middleton, Patrick H. Pun  Kidney International 
M. Fukagawa, S. Nakanishi, J.J. Kazama  Kidney International 
Burden of chronic kidney disease: North Africa
Shared Primacy of Sodium and Potassium on Cardiovascular Risk
Volume 72, Issue 10, Pages (November 2007)
Daniel E. Weiner, MD, MS  American Journal of Kidney Diseases 
Jeffrey C. Fink, Glenn M. Chertow  Kidney International 
Volume 75, Issue 10, Pages (May 2009)
D. Batlle, P. Ramadugu, M.J. Soler  Kidney International 
Volume 74, Issue 3, Pages (August 2008)
Per-Ola Attman, M.D, Petar Alaupovic, Ola Samuelsson 
Volume 70, Issue 11, Pages (December 2006)
Gary C.W. Chan, Sydney C.W. Tang  Kidney International 
Volume 88, Issue 5, Pages (November 2015)
Use of vitamin D in chronic kidney disease patients
Edmund G. Lowrie  Kidney International 
Study of Heart and Renal Protection (SHARP)
Volume 88, Issue 4, Pages (October 2015)
Anemia as a risk factor for cardiovascular disease
Ferruh Artunc, Friedhelm Hildebrandt, Kerstin Amann 
Amit X. Garg, William F. Clark, R. Brian Haynes, Andrew A. House 
Fructose intake as a risk factor for kidney stone disease
Volume 73, Issue 12, Pages (June 2008)
Navdeep Tangri, Paul V.J. Komenda, Claudio Rigatto 
Does reducing salt intake increase cardiovascular mortality?
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Tilman B. Drüeke, Ziad A. Massy  Kidney International 
Daniel E. Weiner, MD, MS, Mark J. Sarnak, MD, MS 
Methods for guideline development
Cardiovascular disease in pediatric chronic dialysis patients
Volume 87, Issue 1, Pages (January 2015)
Volume 76, Issue 8, Pages (October 2009)
The global challenge of chronic kidney disease
Volume 68, Issue 2, Pages (August 2005)
Cardiovascular calcification in patients with chronic renal failure: Are we on target with this risk factor?  Peter A. Mccullough, Sandeep Soman  Kidney.
Volume 85, Issue 5, Pages (May 2014)
Volume 78, Issue 8, Pages (October 2010)
Cardiovascular risk assessment in kidney transplantation
Will there be an epidemic of HIV-related chronic kidney disease in sub-Saharan Africa? Too soon to tell  Kara K. Wools-Kaloustian, Samir K. Gupta  Kidney.
Vitamin D in chronic kidney disease: is the jury in?
Volume 64, Issue 2, Pages (August 2003)
Cardio-Kidney-Damage: a unifying concept
Volume 81, Issue 12, Pages (June 2012)
Volume 87, Issue 1, Pages (January 2015)
Volume 72, Issue 2, Pages (July 2007)
Volume 75, Issue 12, Pages (June 2009)
Effect of proteinuria and glomerular filtration rate on cardiovascular risk in essential hypertension  Julian Segura, Carlos Campo, Luis M. Ruilope  Kidney.
Is it the low-protein diet or simply the salt restriction?
Cardiovascular risk in chronic kidney disease
Fetuin-A is not associated with mortality in chronic kidney disease
Volume 75, Issue 7, Pages (April 2009)
Antioxidant therapy in hemodialysis patients: a systematic review
In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression  B.O. Eriksen, O.C. Ingebretsen  Kidney.
Sugar-sweetened beverages and chronic disease
Presentation transcript:

Cardiovascular risk factors in chronic kidney disease Vandana Menon, Ambreen Gul, Mark J. Sarnak  Kidney International  Volume 68, Issue 4, Pages 1413-1418 (October 2005) DOI: 10.1111/j.1523-1755.2005.00551.x Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 1 Chronic kidney disease (CKD) is a risk factor for cardiovascular disease (CVD) and cardiovascular disease may be a risk factor for progression of chronic kidney disease. Traditional cardiovascular disease risk factors promote the development and progression of both chronic kidney disease and cardiovascular disease. Declining kidney function is associated with elevated levels of traditional and nontraditional cardiovascular disease risk factors. It remains unknown whether nontraditional cardiovascular disease risk factors (dotted arrow) are important risk factors for progression of kidney disease. Reproduced with permission from[7]. Kidney International 2005 68, 1413-1418DOI: (10.1111/j.1523-1755.2005.00551.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 2 Traditional and nontraditional risk factors associated with chronic kidney disease may promote myocardial and blood vessel remodeling resulting in different manifestations of cardiovascular disease (CVD), including cardiomyopathy, atherosclerosis, and arteriosclerosis. The latter subsequently lead to clinical manifestations of cardiovascular disease, including heart failure and ischemic heart disease. Kidney International 2005 68, 1413-1418DOI: (10.1111/j.1523-1755.2005.00551.x) Copyright © 2005 International Society of Nephrology Terms and Conditions